期刊文献+

痰热清注射液治疗脓毒症抗炎作用临床观察 被引量:3

Clinical Observation of Anti-inflammation Effect of Tanreqing Injection in Treating Sepsis
下载PDF
导出
摘要 目的:观察痰热清注射液对脓毒症(SEPSIS)患者的抗炎作用。方法:将脓毒症患者80例随机分为治疗组与对照组各40例,两组均给予西药常规治疗,治疗组在常规治疗的基础上加用痰热清注射液治疗,观察两组治疗前后外周血降钙素原(PCT)、CRP和WBC水平变化及并发症的发生情况。结果:治疗组治疗后外周血PCT、CRP和WBC水平明显下降,对照组则变化不大;治疗组并发症发生率明显低于对照组。结论:痰热清注射液对脓毒症患者炎症因子具有拮抗作用,可阻断全身炎症反应综合征(SIRS)的病理反应过程,改善脓毒症患者的预后。 Objective: To explore the anti-inflammation effect of Tanreqing injection in treating sepsis. Methods:80 cases with sepsis were divided randomly into the treatment group and the contrast group. Both groups were treated by normal westem medicine and the treatment group by Tanreqing additional injection. The levels of PCT, CRP, WBC and the syndrome were observed before and after the treatment. Results:The levels of PCT, CRP and WBC in the treatment group were decreased obviously after treatment while no difference was found in the contrast group. The occurrence ratio of syndrome in the treatment group was significantly lower than that in the contrast group. Conclusion,Tanreqing injection can resist the inflammation gene of sepsis, interdict the pathology response process of systemic inflammatory response syndrome (SIRS) and improve the prognosis of sepsis.
出处 《浙江中西医结合杂志》 2006年第9期533-534,共2页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
关键词 脓毒症 痰热清注射液 抗炎 降钙素原 C-反应蛋白 sepsis tanreqing injection anti-inflammation effect
  • 相关文献

参考文献11

  • 1Levy MM,Fink MP,Marshall JC,et al.International sepsis definitions conference.2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions cofernce.Intensive Care Med,2003,29(4):530 被引量:1
  • 2方文贤等主编..医用中药药理学[M].北京:人民卫生出版社,1998:1043.
  • 3American college of chest physicians/society of critical care medicine consensus conference:definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.Crit Care Med,1992,20(6):864 被引量:1
  • 4Davies MG,Hagen PO.Systemic inflammatory response syndrome.Br J Surg,1997,84(7):920 被引量:1
  • 5Tugrul S,Esen F,Celebi S,et al.Reliability of procalci-tonin as a severity marker in critically ill patients with inflammatory respones.Anaesth Intersive Care,2002,30(6):747 被引量:1
  • 6Bell K,Wattie M,Byth K,et al.Procalcitonin:a marker of bacteraemia in SIRS.Anaesth Intensive Care,2003,31(6):629 被引量:1
  • 7宋秀琴,时兢,谢卫星,杨兴易,陈德昌,林兆奋.降钙素原与全身性感染的相关性研究[J].中国急救医学,2003,23(10):676-677. 被引量:45
  • 8Karzai W,Oberhoffer M,Meier-Hellmann A,et al.Procalcitonin-a mew indicator of the systemic response to severe infections.Infection,1997,25(6):329 被引量:1
  • 9Tiniatti G,Arcone RE,Majello B,et al.Regulation of the human C-reactive protein gene,a maj marker inflammation and cancer.Mol Biol Med,1990,7:199 被引量:1
  • 10刘亮,吕金钰,范君度,薛文斗.内镜与中药联合对治疗对急性化脓性胆管炎血清急性时相蛋白的影响[J].中西医结合实用临床急救,1999,6(6):245-247. 被引量:7

二级参考文献15

  • 1Casey L C, Balk R A, Bone R C. Plasma cytokine and endotoxin concentrations correlate with survival in patients with the sepsis syndrome[J]. Ann Intern Med, 1993, 119: 771-778. 被引量:1
  • 2Panacek E. New direction in severe sepsis research, including IL-6 stratification and TNF - alpha blockade: program and abstracts of the 30th international educational and scientific symposium of the society of critical care medicine[J]. Califomia: San Francisco, 2001. 10- 14. 被引量:1
  • 3American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for the use of innovative therapies in sepsis[J]. Crit Care Med:1992, 20:864-S74. 被引量:1
  • 4Assicot M, Gendrel D, Carsin H, et al . High serum procalcitonin concentrations in patients with sepsis and infection [ J ]. Lancet, 1993,341:515-518. 被引量:1
  • 5Nelyn E S, Whang K T, White J C. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis[J]. Crit Care Med, 1998, 26:1001 - 1006. 被引量:1
  • 6Hack C E, de Groot E R, Felt- Bersma R J, et al. Increased plasma concentrations of interleukin - 6 in sepsis[J]. Blood, 1989, 74:1704 -1710. 被引量:1
  • 7Spittler A, Razenberger M, Kupper H, a al. Relationship between interleukin- 6 plasma concentration in patients with sepsis, monocyte phenotype, monocyte phagocytic properties, and cytokine production[J]. Clin Infect Dis, 2000, 31: 1338- 1420. 被引量:1
  • 8Bernard G R, Vincent J L, Laterre P F, etal. Efficacy and safety of recombinant human activated protein C for severe sepsis [ J ]. N Engl J Med, 2001, 344: 699-709. 被引量:1
  • 9Cruickshand AM ,Fraser WD,Burns HJG,et al. Response of serum interleukin-6 in patients undergoing elective surgery. Clinical Science, 1990,79:160-182. 被引量:1
  • 10Kloosterman B, Mary E, Blomberg PH, et al. Unimpaired immune function after laparoscopic cholecystectomy. Surg,1994,115:424-426. 被引量:1

共引文献53

同被引文献23

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部